drug discovery ai

  1. Astellas Boltz-2 NIM Cuts Drug Assays 90% and Research Time 70%

    Astellas Pharma has deployed NVIDIA’s Boltz-2 NIM to guide membrane-protein drug discovery, using Tokyo-1 as a computational foundation and reporting that 10 selected compounds all showed the expected medicinal effects while evaluated compounds fell by more than 90% and the research period by...